CD8A and graft versus host disease: Using anti-B7-1 (also known as CD80) plus anti-B7-2 (also known as CD86) monoclonal antibodies, it was demonstrated that B7-1 expression on donor T cells is critical for maximal GVHD lethality induced by either CD8+ or CD4+ T cells (24).